Skip to main content

Clinical Analysis of Glioma: Anaplastic Astrocytoma and Glioblastoma

  • Chapter
Treatment of Glioma

Abstract

There have been many reports on the effects of radiotherapy and chemotherapy and on the factors influencing the prognosis of malignant gliomas [1, 3, 5, 6, 10–12, 15, 17, 18]. The approach of most early investigations was historical [e.g., 3, 17, 18], but in recent years the number of randomized studies reporting on the effects of radiotherapy or chemotherapy has increased [1, 5, 10–12]. Among such studies, some have acknowledged the effectiveness of adjuvant chemotherapy [1, 3, 10, 15, 18], but others report negative findings in this regard [5, 12, 17]. In contrast, there has been some uniformity of opinion concerning the effectiveness of radiotherapy [2, 3, 13, 16, 18, 19]. Among such studies, however, many have reported the effects of adjuvant therapy for a group in which glioblastoma and other anaplastic gliomas were discussed together as a single disease entity [1, 3, 5, 12, 17, 18].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Afra D, Kocsis B, Dobay J, Eckhardt S (1983) Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas. J Neurosurg 59: 106–110

    Article  PubMed  CAS  Google Scholar 

  2. Bouchard J, Peirce CB (1960) Radiation therapy in the management of neoplasms of the central nervous system, with a special note in regard to children; twenty years’ experience, 1939–1958. Am J Roentogenol 84: 610–627

    Google Scholar 

  3. Chin HW, Young AB, Maruyama Y (1981) Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center. Cancer Treat Rep 65: 45–51

    PubMed  CAS  Google Scholar 

  4. Cox DR (1972) Regression model and life tables. JR Stat Soc (B) 34: 187–200

    Google Scholar 

  5. European Organization for Research on Treatment of Cancer(EORTC), Brain Tumor Group (1981) Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supra-tentorial brain gliomas. J Neurosurg 55: 27–31

    Article  Google Scholar 

  6. Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E, Batzdorf U, Brooks WH, Hunt WE, Mealey J, Odom GL, Paoletti P, Ransohoff J, Robertson JT, Selker PG, Shapiro WR, Smith KR, Wilson CB, Strike TA (1983) Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as addition to surgery and radiotherapy for the treatment of malignant gliomas. Cancer Treat Rep 67: 121–132

    PubMed  CAS  Google Scholar 

  7. Hoshino T, Wilson CB (1975) Review of basic concepts of cell kinetics as applied to brain tumors. J Neurosurg 42: 123–131

    Article  PubMed  CAS  Google Scholar 

  8. Hoshino T, Wilson CB, Rosenblum ML, Barker M (1975) Chemotherapeutic implications of growth fraction and cell cycle time in glioblastomas. J Neurosurg 43: 127–135

    Article  PubMed  CAS  Google Scholar 

  9. Kaplan EL, Meier P (1958) Nonparametric estimation for incomplete observations. J Am Stat Assoc 53: 457–481

    Article  Google Scholar 

  10. Levin VA, Wilson CB, Davis R, Wara WM, Pisher TL, Irwin L (1979) A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for the treatment of primary malignant gliomas. J Neurosurg 51: 526–532

    Article  PubMed  CAS  Google Scholar 

  11. Levin VA, Wara WM, Davis RL, Vestnys P, Resser KJ, Vatsko K, Nutik S, Gutin PH, Wilson CB (1985) Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. J Neurosurg 63: 218–233

    Article  PubMed  CAS  Google Scholar 

  12. Nelson DF, Shoenfeld D, Weinstein AS, Nelson JS, Wasserman T, Goodman RL, Carabell S (1983) A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of and RTOG study. Int J Rad Oncol Biol Phys 9: 1143–1151

    Article  CAS  Google Scholar 

  13. Poisson M, Pouillart P, Bataini JP, Mashaly R, Pertuiset BF, Metzger J (1979) Malignant gliomas treated after surgery by combination chemotherapy and delayed radiation; I. Analysis of results. Acta Neurochirurgica 51: 15–25

    Article  PubMed  CAS  Google Scholar 

  14. Roth JG, Elvidge AR (1960) Glioblastoma multiforme: A clinical survey. J Neurosurg 17:736–750

    Article  PubMed  CAS  Google Scholar 

  15. Scott GM, Gilbert FB (1980) Epilepsy and other factors in the prognosis of gliomas. Acta Neurol Scandinav 61: 227–239

    Article  CAS  Google Scholar 

  16. Seiler RW, Greiner RH, Zimmerman A, Markwalder H (1978) Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas. J Neurosurg 48: 861–865

    Article  PubMed  CAS  Google Scholar 

  17. Stage WS, Stein JJ (1974) Treatment of malignant astrocytomas. Am J Roentogenol 120:7–18

    CAS  Google Scholar 

  18. Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealer J Jr, Norrell HA, Qwens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49: 333–343

    Article  PubMed  CAS  Google Scholar 

  19. Weir B, MSc, Frcs(C) (1973) The relative significance of factors affecting postoperative survival in astrocytomas, grade 3 and 4. J Neurosurg 38: 448–452

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Tokyo

About this chapter

Cite this chapter

Shingai, J., Kanno, M. (1988). Clinical Analysis of Glioma: Anaplastic Astrocytoma and Glioblastoma. In: Suzuki, J. (eds) Treatment of Glioma. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68453-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68453-4_9

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68455-8

  • Online ISBN: 978-4-431-68453-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics